Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity
The expression of ACE2 is linked to disease severity in COVID-19 patients. The ACE2 receptor gene polymorphisms are considered determinants for SARS-CoV-2 infection and its outcome. In our study, serum ACE2 and its genetic variant S19P rs73635825 polymorphism were investigated in 114 SARS-CoV-2 pati...
Saved in:
Published in | Scientific reports Vol. 14; no. 1; pp. 5846 - 13 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
10.03.2024
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The expression of ACE2 is linked to disease severity in COVID-19 patients. The ACE2 receptor gene polymorphisms are considered determinants for SARS-CoV-2 infection and its outcome. In our study, serum ACE2 and its genetic variant S19P rs73635825 polymorphism were investigated in 114 SARS-CoV-2 patients. The results were compared with 120 control subjects. ELISA technique and allele discrimination assay were used for measuring serum ACE2 and genotype analysis of ACE2 rs73635825. Our results revealed that serum ACE2 was significantly lower in SARS-CoV-2 patients (
p =
0.0001), particularly in cases with hypertension or diabetes mellitus. There was a significant difference in the genotype distributions of ACE2 rs73635825 A > G between COVID-19 patients and controls (
p
-value = 0.001). A higher frequency of the heterozygous AG genotype (65.8%) was reported in COVID-19 patients. The G allele was significantly more common in COVID-19 patients (
p <
0.0001). The AG and GG genotypes were associated with COVID-19 severity as they were correlated with abnormal laboratory findings, GGO, CXR, and total severity scores with
p <
0.05. Our results revealed that the ACE2 S19P gene variant is correlated with the incidence of infection and its severity, suggesting the usefulness of this work in identifying the susceptible population groups for better disease control. |
---|---|
AbstractList | The expression of ACE2 is linked to disease severity in COVID-19 patients. The ACE2 receptor gene polymorphisms are considered determinants for SARS-CoV-2 infection and its outcome. In our study, serum ACE2 and its genetic variant S19P rs73635825 polymorphism were investigated in 114 SARS-CoV-2 patients. The results were compared with 120 control subjects. ELISA technique and allele discrimination assay were used for measuring serum ACE2 and genotype analysis of ACE2 rs73635825. Our results revealed that serum ACE2 was significantly lower in SARS-CoV-2 patients (p = 0.0001), particularly in cases with hypertension or diabetes mellitus. There was a significant difference in the genotype distributions of ACE2 rs73635825 A > G between COVID-19 patients and controls (p-value = 0.001). A higher frequency of the heterozygous AG genotype (65.8%) was reported in COVID-19 patients. The G allele was significantly more common in COVID-19 patients (p < 0.0001). The AG and GG genotypes were associated with COVID-19 severity as they were correlated with abnormal laboratory findings, GGO, CXR, and total severity scores with p < 0.05. Our results revealed that the ACE2 S19P gene variant is correlated with the incidence of infection and its severity, suggesting the usefulness of this work in identifying the susceptible population groups for better disease control. The expression of ACE2 is linked to disease severity in COVID-19 patients. The ACE2 receptor gene polymorphisms are considered determinants for SARS-CoV-2 infection and its outcome. In our study, serum ACE2 and its genetic variant S19P rs73635825 polymorphism were investigated in 114 SARS-CoV-2 patients. The results were compared with 120 control subjects. ELISA technique and allele discrimination assay were used for measuring serum ACE2 and genotype analysis of ACE2 rs73635825. Our results revealed that serum ACE2 was significantly lower in SARS-CoV-2 patients ( p = 0.0001), particularly in cases with hypertension or diabetes mellitus. There was a significant difference in the genotype distributions of ACE2 rs73635825 A > G between COVID-19 patients and controls ( p -value = 0.001). A higher frequency of the heterozygous AG genotype (65.8%) was reported in COVID-19 patients. The G allele was significantly more common in COVID-19 patients ( p < 0.0001). The AG and GG genotypes were associated with COVID-19 severity as they were correlated with abnormal laboratory findings, GGO, CXR, and total severity scores with p < 0.05. Our results revealed that the ACE2 S19P gene variant is correlated with the incidence of infection and its severity, suggesting the usefulness of this work in identifying the susceptible population groups for better disease control. Abstract The expression of ACE2 is linked to disease severity in COVID-19 patients. The ACE2 receptor gene polymorphisms are considered determinants for SARS-CoV-2 infection and its outcome. In our study, serum ACE2 and its genetic variant S19P rs73635825 polymorphism were investigated in 114 SARS-CoV-2 patients. The results were compared with 120 control subjects. ELISA technique and allele discrimination assay were used for measuring serum ACE2 and genotype analysis of ACE2 rs73635825. Our results revealed that serum ACE2 was significantly lower in SARS-CoV-2 patients (p = 0.0001), particularly in cases with hypertension or diabetes mellitus. There was a significant difference in the genotype distributions of ACE2 rs73635825 A > G between COVID-19 patients and controls (p-value = 0.001). A higher frequency of the heterozygous AG genotype (65.8%) was reported in COVID-19 patients. The G allele was significantly more common in COVID-19 patients (p < 0.0001). The AG and GG genotypes were associated with COVID-19 severity as they were correlated with abnormal laboratory findings, GGO, CXR, and total severity scores with p < 0.05. Our results revealed that the ACE2 S19P gene variant is correlated with the incidence of infection and its severity, suggesting the usefulness of this work in identifying the susceptible population groups for better disease control. The expression of ACE2 is linked to disease severity in COVID-19 patients. The ACE2 receptor gene polymorphisms are considered determinants for SARS-CoV-2 infection and its outcome. In our study, serum ACE2 and its genetic variant S19P rs73635825 polymorphism were investigated in 114 SARS-CoV-2 patients. The results were compared with 120 control subjects. ELISA technique and allele discrimination assay were used for measuring serum ACE2 and genotype analysis of ACE2 rs73635825. Our results revealed that serum ACE2 was significantly lower in SARS-CoV-2 patients (p = 0.0001), particularly in cases with hypertension or diabetes mellitus. There was a significant difference in the genotype distributions of ACE2 rs73635825 A > G between COVID-19 patients and controls (p-value = 0.001). A higher frequency of the heterozygous AG genotype (65.8%) was reported in COVID-19 patients. The G allele was significantly more common in COVID-19 patients (p < 0.0001). The AG and GG genotypes were associated with COVID-19 severity as they were correlated with abnormal laboratory findings, GGO, CXR, and total severity scores with p < 0.05. Our results revealed that the ACE2 S19P gene variant is correlated with the incidence of infection and its severity, suggesting the usefulness of this work in identifying the susceptible population groups for better disease control.The expression of ACE2 is linked to disease severity in COVID-19 patients. The ACE2 receptor gene polymorphisms are considered determinants for SARS-CoV-2 infection and its outcome. In our study, serum ACE2 and its genetic variant S19P rs73635825 polymorphism were investigated in 114 SARS-CoV-2 patients. The results were compared with 120 control subjects. ELISA technique and allele discrimination assay were used for measuring serum ACE2 and genotype analysis of ACE2 rs73635825. Our results revealed that serum ACE2 was significantly lower in SARS-CoV-2 patients (p = 0.0001), particularly in cases with hypertension or diabetes mellitus. There was a significant difference in the genotype distributions of ACE2 rs73635825 A > G between COVID-19 patients and controls (p-value = 0.001). A higher frequency of the heterozygous AG genotype (65.8%) was reported in COVID-19 patients. The G allele was significantly more common in COVID-19 patients (p < 0.0001). The AG and GG genotypes were associated with COVID-19 severity as they were correlated with abnormal laboratory findings, GGO, CXR, and total severity scores with p < 0.05. Our results revealed that the ACE2 S19P gene variant is correlated with the incidence of infection and its severity, suggesting the usefulness of this work in identifying the susceptible population groups for better disease control. |
ArticleNumber | 5846 |
Author | Wahb, Amany M. Zaki, Kamelia Ahmed Shokr, Mohamed Shaker, Olfat Gaber, Dalia A. Khalil, Haidy Samir |
Author_xml | – sequence: 1 givenname: Dalia A. orcidid: 0000-0003-2676-9152 surname: Gaber fullname: Gaber, Dalia A. email: dalia.ali@med.helwan.edu.eg, dr.dalia@gmu.ac.ae organization: Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Helwan University, College of Medicine, Gulf Medical University – sequence: 2 givenname: Mohamed orcidid: 0009-0008-6805-4810 surname: Shokr fullname: Shokr, Mohamed organization: Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, MUST University – sequence: 3 givenname: Olfat orcidid: 0000-0002-3031-3599 surname: Shaker fullname: Shaker, Olfat organization: Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University – sequence: 4 givenname: Kamelia Ahmed surname: Zaki fullname: Zaki, Kamelia Ahmed organization: Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, MUST University – sequence: 5 givenname: Haidy Samir surname: Khalil fullname: Khalil, Haidy Samir organization: Medical Microbiology and Immunology, Faculty of Medicine, Helwan University – sequence: 6 givenname: Amany M. orcidid: 0000-0001-7063-4285 surname: Wahb fullname: Wahb, Amany M. organization: Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Helwan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38462662$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhSNURB_0D7BAltiwCfiZ2GxQNUxhpEpFKrC1nOQm41FiBzspmn-PpymlZYEly4985_jq5pxmR847yLJXBL8jmMn3kROhZI4pz0VBC5wXz7ITirnIKaP06NH-ODuPcYfTEFRxol5kx0zypCnoSTbfQJgHdLFaU2Rcg26I-oo6cIBG3-8HH8atjQOyDq27_ThZ49BoJgtuiuiXnbZodf1j8yknKiEt1JP17gOqfQjQm8NhgRobwURAEW4h2Gn_Mnvemj7C-f16ln2_XH9bfcmvrj9vVhdXec0VnXLguKFt24JkFCRg3IAxjChVybKkRggBDeMM0pRYtJXEpFCmxgZkWRnF2Fm2WXwbb3Z6DHYwYa-9sfruwodOmzDZugfdlBVnnOCSqYqn1lS8LTFXhZACKLRN8vq4eI1zNUBTpxYE0z8xffrF2a3u_K0mWFEhpEwOb-8dgv85Q5z0YGMNfW8c-DlqqoSgheRYJPTNP-jOz8GlXh0oXohUKE_U68clPdTy5_cmgC5AHXyMAdoHhGB9iJFeYqRTjPRdjHSRRGwRxQS7DsLft_-j-g10qcjA |
Cites_doi | 10.3389/fped.2020.00206 10.3390/ijms21103474 10.3390/jpm11111098 10.3390/genes11070741 10.1016/j.gene.2020.145102 10.3390/v13010067 10.1002/ddr.21656 10.3389/fgene.2022.888025 10.1016/j.ejim.2020.04.037 10.1097/FPC.0000000000000436 10.2147/IJGM.S310577 10.1093/ehjcvp/pvaa053 10.2174/1871526520666200518073329 10.3389/fmed.2020.00335 10.1002/mgg3.1344 10.1016/j.jmii.2020.04.015 10.1111/acel.13168 10.1016/j.phrs.2020.104833 10.3390/v14071451 10.3390/ijerph17103433 10.1016/S0140-6736(20)30211-7 10.3389/fmed.2020.563893 10.1371/journal.pone.0252799 10.1148/radiol.2020201473 10.1016/j.expneurol.2021.113837 10.1148/ryct.2020200213 10.1186/s12985-022-01782-6 10.1183/13993003.01112-2020 10.1016/j.vph.2021.106934 10.1001/jamacardio.2020.1282 10.1139/gen-2020-0124 10.1186/s13054-020-03120-0 10.3389/fcimb.2021 10.1016/j.cell.2023.01.039 10.3760/cma.j.issn.1001-0939.2020.03.016 10.1161/01.res.87.5.e1 10.17219/acem/163409 10.1016/j.cca.2020.08.019 10.1016/j.lfs.2020.117905 10.1016/j.genrep.2020.100979 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.1038/s41598-024-56260-6 |
DatabaseName | SpringerOpen Free (Free internet resource, activated by CARLI) CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_d7b43410739b4662b4f70496585e2efd PMC10925588 38462662 10_1038_s41598_024_56260_6 |
Genre | Journal Article |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT NPM 7XB 8FK AARCD COVID K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c492t-e40d2fffe832e8e00deaa3199b8772a555ed343e343805fb80169ac0ae87ba933 |
IEDL.DBID | 7X7 |
ISSN | 2045-2322 |
IngestDate | Wed Aug 27 01:26:15 EDT 2025 Thu Aug 21 18:34:44 EDT 2025 Fri Jul 11 08:30:41 EDT 2025 Wed Aug 13 09:11:59 EDT 2025 Thu Apr 03 07:04:38 EDT 2025 Tue Jul 01 00:51:34 EDT 2025 Fri Feb 21 02:37:51 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c492t-e40d2fffe832e8e00deaa3199b8772a555ed343e343805fb80169ac0ae87ba933 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-2676-9152 0000-0001-7063-4285 0009-0008-6805-4810 0000-0002-3031-3599 |
OpenAccessLink | https://www.proquest.com/docview/2954651074?pq-origsite=%requestingapplication% |
PMID | 38462662 |
PQID | 2954651074 |
PQPubID | 2041939 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d7b43410739b4662b4f70496585e2efd pubmedcentral_primary_oai_pubmedcentral_nih_gov_10925588 proquest_miscellaneous_2955268405 proquest_journals_2954651074 pubmed_primary_38462662 crossref_primary_10_1038_s41598_024_56260_6 springer_journals_10_1038_s41598_024_56260_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-03-10 |
PublicationDateYYYYMMDD | 2024-03-10 |
PublicationDate_xml | – month: 03 year: 2024 text: 2024-03-10 day: 10 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2024 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Hernández (CR35) 2021; 345 Möhlendick (CR16) 2021; 31 Vadgama (CR25) 2020; 13 Fan, Lu, Li, Ding, Wang (CR34) 2021; 7 Pagliaro, Penna (CR5) 2020; 7 Khothari (CR44) 2004 Ciaglia, Vecchione, Puca (CR28) 2020; 8 de Jaegere, Krdzalic, Fasen, Kwee (CR23) 2020; 2 Gómez (CR41) 2020; 762 Strafella, Caputo, Termine, Barati, Gambardella, Borgiani, Caltagirone, Novelli, Giardina, Cascella (CR36) 2020; 11 Devaux, Rolain, Raoult (CR14) 2020; 53 Pourbagheri-Sigaroodi, Bashash, Fateh, Abolghasemi (CR33) 2020; 510 Beacon, Delcuve, Davie (CR13) 2021; 64 Sun, Yang, Sun, Su (CR7) 2020; 43 Ni (CR12) 2020; 24 Banu, Panikar, Leal, Leal (CR3) 2020; 256 Bavishi, Maddox, Messerli (CR1) 2020; 5 Mir (CR43) 2021; 11 Oudit (CR27) 2023; 186 Setiawati (CR24) 2021; 9 Ciaglia, Vecchione, Puca (CR8) 2020; 8 Li, Cao, Rahman (CR20) 2020; 8 Annweiler (CR6) 2020; 20 Paniri, Hosseini, Moballegh-Eslam, Akhavan-Niaki (CR19) 2021; 22 Gurwitz (CR9) 2020; 81 Alimoradi (CR15) 2022; 19 Darbani (CR18) 2020; 17 Donoghue (CR2) 2000; 87 Offringa (CR10) 2020; 6 Liu (CR32) 2020; 55 Akbari (CR39) 2022; 142 Chen (CR29) 2020; 395 Chen (CR40) 2021; 11 Hu, Bauer, Sawyer, Diaz-Griffero (CR21) 2022; 14 Hashizume (CR26) 2021; 13 Prokop (CR22) 2020; 296 Tug (CR31) 2023 Möhlendick (CR42) 2021; 31 Gemmati (CR17) 2020; 21 Kragstrup (CR38) 2021; 16 Li, Zhou, Yang, You (CR4) 2020; 157 Chen (CR37) 2020; 19 Verdecchia, Cavallini, Spanevello, Angeli (CR11) 2020; 76 Alimoradi, Sharqi, Firouzabadi, Sadeghi, Moezzi (CR30) 2022; 19 CR Khothari (56260_CR44) 2004 J Chen (56260_CR37) 2020; 19 A Paniri (56260_CR19) 2021; 22 R Setiawati (56260_CR24) 2021; 9 M Donoghue (56260_CR2) 2000; 87 CA Devaux (56260_CR14) 2020; 53 N Banu (56260_CR3) 2020; 256 A Pourbagheri-Sigaroodi (56260_CR33) 2020; 510 C Fan (56260_CR34) 2021; 7 GY Oudit (56260_CR27) 2023; 186 D Gurwitz (56260_CR9) 2020; 81 P Pagliaro (56260_CR5) 2020; 7 Y Liu (56260_CR32) 2020; 55 M Mir (56260_CR43) 2021; 11 B Möhlendick (56260_CR42) 2021; 31 E Ciaglia (56260_CR28) 2020; 8 C Annweiler (56260_CR6) 2020; 20 C Bavishi (56260_CR1) 2020; 5 E Tug (56260_CR31) 2023 P Hu (56260_CR21) 2022; 14 E Ciaglia (56260_CR8) 2020; 8 W Ni (56260_CR12) 2020; 24 ML Sun (56260_CR7) 2020; 43 B Darbani (56260_CR18) 2020; 17 M Akbari (56260_CR39) 2022; 142 A Offringa (56260_CR10) 2020; 6 B Möhlendick (56260_CR16) 2021; 31 TMH de Jaegere (56260_CR23) 2020; 2 N Alimoradi (56260_CR15) 2022; 19 C Strafella (56260_CR36) 2020; 11 TW Kragstrup (56260_CR38) 2021; 16 N Alimoradi (56260_CR30) 2022; 19 Y Li (56260_CR4) 2020; 157 D Gemmati (56260_CR17) 2020; 21 J Gómez (56260_CR41) 2020; 762 TH Beacon (56260_CR13) 2021; 64 Q Li (56260_CR20) 2020; 8 N Chen (56260_CR29) 2020; 395 M Hashizume (56260_CR26) 2021; 13 N Vadgama (56260_CR25) 2020; 13 F Chen (56260_CR40) 2021; 11 VS Hernández (56260_CR35) 2021; 345 P Verdecchia (56260_CR11) 2020; 76 M Prokop (56260_CR22) 2020; 296 |
References_xml | – volume: 8 start-page: 206 year: 2020 ident: CR8 article-title: COVID-19 infection and circulating ACE2 levels: Protective role in women and children publication-title: Front. Pediatr. doi: 10.3389/fped.2020.00206 – volume: 21 start-page: 3474 issue: 10 year: 2020 ident: CR17 article-title: COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females be protective against SARS-CoV-2 compared to the single X-chromosome in males? publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21103474 – volume: 11 start-page: 1098 issue: 11 year: 2021 ident: CR43 article-title: Strong association of angiotensin converting enzyme-2 gene insertion/deletion polymorphism with susceptibility to SARS-CoV-2, hypertension, coronary artery disease and COVID-19 disease mortality publication-title: J. Pers. Med. doi: 10.3390/jpm11111098 – volume: 11 start-page: 741 issue: 7 year: 2020 ident: CR36 article-title: Analysis of genetic variability among populations highlights a possible link with COVID-19-related neurological complications publication-title: Genes doi: 10.3390/genes11070741 – volume: 762 start-page: 145102 year: 2020 ident: CR41 article-title: Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome publication-title: Gene doi: 10.1016/j.gene.2020.145102 – volume: 13 start-page: 67 issue: 1 year: 2021 ident: CR26 article-title: Population-specific single-nucleotide polymorphisms have limited impact on SARS-CoV-2 infectivity in vitro publication-title: Viruses doi: 10.3390/v13010067 – volume: 81 start-page: 537 year: 2020 end-page: 540 ident: CR9 article-title: Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics publication-title: Drug Dev. Res. doi: 10.1002/ddr.21656 – volume: 13 start-page: 888025 year: 2020 ident: CR25 article-title: SARS-CoV-2 susceptibility and ACE2 gene variations within diverse ethnic backgrounds publication-title: Front. Genet. doi: 10.3389/fgene.2022.888025 – volume: 76 start-page: 14 year: 2020 end-page: 20 ident: CR11 article-title: The pivotal link between ACE2 deficiency and SARS-CoV-2 infection publication-title: Eur. J. Intern. Med. doi: 10.1016/j.ejim.2020.04.037 – volume: 31 start-page: 165 issue: 8 year: 2021 end-page: 171 ident: CR42 article-title: ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19 publication-title: Pharmacogenet. Genom. doi: 10.1097/FPC.0000000000000436 – volume: 9 start-page: 2407 issue: 14 year: 2021 end-page: 2412 ident: CR24 article-title: Modified chest X-ray scoring system in evaluating severity of COVID-19 patient in Dr. Soetomo General Hospital Surabaya, Indonesia publication-title: Int. J. Gen. Med. doi: 10.2147/IJGM.S310577 – volume: 6 start-page: 317 year: 2020 end-page: 325 ident: CR10 article-title: The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: Possible treatment options related to the renin-angiotensin system publication-title: Eur. Heart J. Cardiovasc. Pharmacother. doi: 10.1093/ehjcvp/pvaa053 – volume: 20 start-page: 407 year: 2020 end-page: 408 ident: CR6 article-title: Counter-regulatory ‘Renin-Angiotensin’ system-based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-infected patients publication-title: Infect. Disord. Drug Targets. doi: 10.2174/1871526520666200518073329 – volume: 7 start-page: 335 year: 2020 ident: CR5 article-title: ACE/ACE2 ratio: A key also in 2019 coronavirus disease (Covid-19)? publication-title: Front. Med. doi: 10.3389/fmed.2020.00335 – volume: 8 start-page: e1344 year: 2020 ident: CR20 article-title: Genetic variability of human angiotensin-converting enzyme 2 (hACE2) among various ethnic populations publication-title: Mol. Genet. Genom. Med. doi: 10.1002/mgg3.1344 – volume: 53 start-page: 425 issue: 3 year: 2020 end-page: 435 ident: CR14 article-title: ACE2 receptor polymorphism: Susceptibility to SARS CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome publication-title: J. Microbiol. Immunol. Infect. doi: 10.1016/j.jmii.2020.04.015 – volume: 19 start-page: e13168 issue: 7 year: 2020 ident: CR37 article-title: Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation publication-title: Aging Cell. doi: 10.1111/acel.13168 – volume: 157 start-page: 104833 year: 2020 ident: CR4 article-title: Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2020.104833 – volume: 14 start-page: 1451 issue: 7 year: 2022 ident: CR21 article-title: Human ACE2 polymorphisms from different human populations modulate SARS-CoV-2 infection publication-title: Viruses. doi: 10.3390/v14071451 – volume: 17 start-page: 3433 issue: 10 year: 2020 ident: CR18 article-title: The expression and polymorphism of entry machinery for COVID-19 in human: Juxtaposing population groups, gender, and different tissues publication-title: Int. J. Environ. Res. Public Health. doi: 10.3390/ijerph17103433 – volume: 395 start-page: 507 year: 2020 end-page: 513 ident: CR29 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study publication-title: Lancet. doi: 10.1016/S0140-6736(20)30211-7 – volume: 7 start-page: 563893 year: 2021 ident: CR34 article-title: ACE2 Expression in kidney and testis may cause kidney and testis infection in COVID-19 patients publication-title: Front Med doi: 10.3389/fmed.2020.563893 – volume: 16 start-page: e0252799 issue: 6 year: 2021 ident: CR38 article-title: Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients publication-title: PLoS ONE. doi: 10.1371/journal.pone.0252799 – volume: 296 start-page: E97 issue: 2 year: 2020 end-page: E104 ident: CR22 article-title: COVID-19 standardized reporting working group of the Dutch radiological society. CO-RADS: A categorical CT assessment scheme for patients suspected of having COVID-19-definition and evaluation publication-title: Radiology. doi: 10.1148/radiol.2020201473 – volume: 345 start-page: 113837 year: 2021 ident: CR35 article-title: ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2021.113837 – volume: 2 start-page: e200213 issue: 3 year: 2020 ident: CR23 article-title: Investigators South-East Netherlands (CISEN) study group. Radiological society of North America Chest CT classification system for reporting COVID-19 pneumonia: Interobserver variability and correlation with reverse-transcription polymerase chain reaction publication-title: Radiol. Cardiothorac. Imaging. doi: 10.1148/ryct.2020200213 – volume: 8 start-page: 206 year: 2020 ident: CR28 article-title: COVID-19 infection and circulating ACE2 levels: Protective role in women and children publication-title: Front. Pead. doi: 10.3389/fped.2020.00206 – volume: 19 start-page: 48 issue: 1 year: 2022 ident: CR30 article-title: SNPs of (rs4343) and (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease publication-title: Virol. J. doi: 10.1186/s12985-022-01782-6 – volume: 55 start-page: 2001112 issue: 5 year: 2020 ident: CR32 article-title: Association between age and clinical characteristics and outcomes of COVID-19 publication-title: Eur. Respir. J. doi: 10.1183/13993003.01112-2020 – volume: 31 start-page: 165 issue: 8 year: 2021 end-page: 171 ident: CR16 article-title: polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19 publication-title: Pharmacogenet. Genomics. doi: 10.1097/FPC.0000000000000436 – volume: 142 start-page: 106934 year: 2022 ident: CR39 article-title: Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients publication-title: Vascul. Pharmacol. doi: 10.1016/j.vph.2021.106934 – volume: 5 start-page: 745 issue: 7 year: 2020 end-page: 747 ident: CR1 article-title: Coronavirus disease 2019 (COVID-19) infection and renin angiotensin system blockers publication-title: JAMA Cardiol. doi: 10.1001/jamacardio.2020.1282 – volume: 64 start-page: 386 issue: 4 year: 2021 end-page: 399 ident: CR13 article-title: Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus publication-title: Genome. doi: 10.1139/gen-2020-0124 – volume: 19 start-page: 48 issue: 1 year: 2022 ident: CR15 article-title: SNPs of (rs4343) and (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease publication-title: Virol. J. doi: 10.1186/s12985-022-01782-6 – volume: 24 start-page: 422 year: 2020 ident: CR12 article-title: Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 publication-title: Crit. Care doi: 10.1186/s13054-020-03120-0 – volume: 11 start-page: 753721 year: 2021 ident: CR40 article-title: The impact of ACE2 polymorphisms on COVID-19 disease: Susceptibility, severity, and therapy publication-title: Front. Cell Infect. Microbiol. doi: 10.3389/fcimb.2021 – volume: 186 start-page: 906 issue: 5 year: 2023 end-page: 922 ident: CR27 article-title: Angiotensin-converting enzyme 2 at the heart of the COVID-19 pandemic publication-title: Cell. doi: 10.1016/j.cell.2023.01.039 – volume: 43 start-page: 219 year: 2020 end-page: 222 ident: CR7 article-title: Inhibitors of RAS might be a good choice for the therapy of COVID-19 Pneumonia publication-title: Zhonghua Jie He He Hu Xi Za Zhi doi: 10.3760/cma.j.issn.1001-0939.2020.03.016 – volume: 87 start-page: e1 year: 2000 end-page: e9 ident: CR2 article-title: A novel angiotensin-converting enzyme related carboxypeptidase. (ACE2) converts angiotensin I to angiotensin 1e9 publication-title: Circ. Res. doi: 10.1161/01.res.87.5.e1 – year: 2023 ident: CR31 article-title: The relationship between the clinical course of SARS-CoV-2 infections and ACE2 and TMPRSS2 expression and polymorphisms publication-title: Adv. Clin. Exp. Med. doi: 10.17219/acem/163409 – volume: 510 start-page: 475 year: 2020 end-page: 482 ident: CR33 article-title: Laboratory findings in COVID-19 diagnosis and prognosis publication-title: Clin. Chim. Acta. doi: 10.1016/j.cca.2020.08.019 – volume: 256 start-page: 117905 year: 2020 ident: CR3 article-title: Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage activation syndrome: Therapeutic implications publication-title: Life Sci. doi: 10.1016/j.lfs.2020.117905 – volume: 22 start-page: 100979 year: 2021 ident: CR19 article-title: Comprehensive in silico identification of impacts of SNPs on COVID-19 susceptibility in different populations publication-title: Gene Rep. doi: 10.1016/j.genrep.2020.100979 – year: 2004 ident: CR44 publication-title: Research Methodology: Methods and Techniques – volume: 21 start-page: 3474 issue: 10 year: 2020 ident: 56260_CR17 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21103474 – volume: 11 start-page: 741 issue: 7 year: 2020 ident: 56260_CR36 publication-title: Genes doi: 10.3390/genes11070741 – volume: 5 start-page: 745 issue: 7 year: 2020 ident: 56260_CR1 publication-title: JAMA Cardiol. doi: 10.1001/jamacardio.2020.1282 – volume: 13 start-page: 67 issue: 1 year: 2021 ident: 56260_CR26 publication-title: Viruses doi: 10.3390/v13010067 – volume: 14 start-page: 1451 issue: 7 year: 2022 ident: 56260_CR21 publication-title: Viruses. doi: 10.3390/v14071451 – volume: 510 start-page: 475 year: 2020 ident: 56260_CR33 publication-title: Clin. Chim. Acta. doi: 10.1016/j.cca.2020.08.019 – year: 2023 ident: 56260_CR31 publication-title: Adv. Clin. Exp. Med. doi: 10.17219/acem/163409 – volume: 16 start-page: e0252799 issue: 6 year: 2021 ident: 56260_CR38 publication-title: PLoS ONE. doi: 10.1371/journal.pone.0252799 – volume: 31 start-page: 165 issue: 8 year: 2021 ident: 56260_CR42 publication-title: Pharmacogenet. Genom. doi: 10.1097/FPC.0000000000000436 – volume: 76 start-page: 14 year: 2020 ident: 56260_CR11 publication-title: Eur. J. Intern. Med. doi: 10.1016/j.ejim.2020.04.037 – volume: 31 start-page: 165 issue: 8 year: 2021 ident: 56260_CR16 publication-title: Pharmacogenet. Genomics. doi: 10.1097/FPC.0000000000000436 – volume: 19 start-page: 48 issue: 1 year: 2022 ident: 56260_CR30 publication-title: Virol. J. doi: 10.1186/s12985-022-01782-6 – volume: 157 start-page: 104833 year: 2020 ident: 56260_CR4 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2020.104833 – volume: 6 start-page: 317 year: 2020 ident: 56260_CR10 publication-title: Eur. Heart J. Cardiovasc. Pharmacother. doi: 10.1093/ehjcvp/pvaa053 – volume: 9 start-page: 2407 issue: 14 year: 2021 ident: 56260_CR24 publication-title: Int. J. Gen. Med. doi: 10.2147/IJGM.S310577 – volume: 8 start-page: 206 year: 2020 ident: 56260_CR28 publication-title: Front. Pead. doi: 10.3389/fped.2020.00206 – volume: 8 start-page: e1344 year: 2020 ident: 56260_CR20 publication-title: Mol. Genet. Genom. Med. doi: 10.1002/mgg3.1344 – volume: 87 start-page: e1 year: 2000 ident: 56260_CR2 publication-title: Circ. Res. doi: 10.1161/01.res.87.5.e1 – volume: 64 start-page: 386 issue: 4 year: 2021 ident: 56260_CR13 publication-title: Genome. doi: 10.1139/gen-2020-0124 – volume: 53 start-page: 425 issue: 3 year: 2020 ident: 56260_CR14 publication-title: J. Microbiol. Immunol. Infect. doi: 10.1016/j.jmii.2020.04.015 – volume: 345 start-page: 113837 year: 2021 ident: 56260_CR35 publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2021.113837 – volume-title: Research Methodology: Methods and Techniques year: 2004 ident: 56260_CR44 – volume: 55 start-page: 2001112 issue: 5 year: 2020 ident: 56260_CR32 publication-title: Eur. Respir. J. doi: 10.1183/13993003.01112-2020 – volume: 142 start-page: 106934 year: 2022 ident: 56260_CR39 publication-title: Vascul. Pharmacol. doi: 10.1016/j.vph.2021.106934 – volume: 11 start-page: 1098 issue: 11 year: 2021 ident: 56260_CR43 publication-title: J. Pers. Med. doi: 10.3390/jpm11111098 – volume: 762 start-page: 145102 year: 2020 ident: 56260_CR41 publication-title: Gene doi: 10.1016/j.gene.2020.145102 – volume: 2 start-page: e200213 issue: 3 year: 2020 ident: 56260_CR23 publication-title: Radiol. Cardiothorac. Imaging. doi: 10.1148/ryct.2020200213 – volume: 19 start-page: e13168 issue: 7 year: 2020 ident: 56260_CR37 publication-title: Aging Cell. doi: 10.1111/acel.13168 – volume: 19 start-page: 48 issue: 1 year: 2022 ident: 56260_CR15 publication-title: Virol. J. doi: 10.1186/s12985-022-01782-6 – volume: 7 start-page: 563893 year: 2021 ident: 56260_CR34 publication-title: Front Med doi: 10.3389/fmed.2020.563893 – volume: 17 start-page: 3433 issue: 10 year: 2020 ident: 56260_CR18 publication-title: Int. J. Environ. Res. Public Health. doi: 10.3390/ijerph17103433 – volume: 11 start-page: 753721 year: 2021 ident: 56260_CR40 publication-title: Front. Cell Infect. Microbiol. doi: 10.3389/fcimb.2021 – volume: 20 start-page: 407 year: 2020 ident: 56260_CR6 publication-title: Infect. Disord. Drug Targets. doi: 10.2174/1871526520666200518073329 – volume: 43 start-page: 219 year: 2020 ident: 56260_CR7 publication-title: Zhonghua Jie He He Hu Xi Za Zhi doi: 10.3760/cma.j.issn.1001-0939.2020.03.016 – volume: 22 start-page: 100979 year: 2021 ident: 56260_CR19 publication-title: Gene Rep. doi: 10.1016/j.genrep.2020.100979 – volume: 256 start-page: 117905 year: 2020 ident: 56260_CR3 publication-title: Life Sci. doi: 10.1016/j.lfs.2020.117905 – volume: 24 start-page: 422 year: 2020 ident: 56260_CR12 publication-title: Crit. Care doi: 10.1186/s13054-020-03120-0 – volume: 7 start-page: 335 year: 2020 ident: 56260_CR5 publication-title: Front. Med. doi: 10.3389/fmed.2020.00335 – volume: 186 start-page: 906 issue: 5 year: 2023 ident: 56260_CR27 publication-title: Cell. doi: 10.1016/j.cell.2023.01.039 – volume: 8 start-page: 206 year: 2020 ident: 56260_CR8 publication-title: Front. Pediatr. doi: 10.3389/fped.2020.00206 – volume: 81 start-page: 537 year: 2020 ident: 56260_CR9 publication-title: Drug Dev. Res. doi: 10.1002/ddr.21656 – volume: 296 start-page: E97 issue: 2 year: 2020 ident: 56260_CR22 publication-title: Radiology. doi: 10.1148/radiol.2020201473 – volume: 395 start-page: 507 year: 2020 ident: 56260_CR29 publication-title: Lancet. doi: 10.1016/S0140-6736(20)30211-7 – volume: 13 start-page: 888025 year: 2020 ident: 56260_CR25 publication-title: Front. Genet. doi: 10.3389/fgene.2022.888025 |
SSID | ssj0000529419 |
Score | 2.4127073 |
Snippet | The expression of ACE2 is linked to disease severity in COVID-19 patients. The ACE2 receptor gene polymorphisms are considered determinants for SARS-CoV-2... Abstract The expression of ACE2 is linked to disease severity in COVID-19 patients. The ACE2 receptor gene polymorphisms are considered determinants for... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 5846 |
SubjectTerms | 631/250 631/326 631/337 631/45 ACE2 Alleles Angiotensin-converting enzyme 2 COVID-19 Diabetes mellitus Disease control Enzyme-linked immunosorbent assay Gene polymorphism Genetic diversity Genetic variance Genotype & phenotype Genotypes Humanities and Social Sciences Hypertension Infections multidisciplinary Polymorphism Science Science (multidisciplinary) Severe acute respiratory syndrome coronavirus 2 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yIHgR12e7q0TwpmG78-hJvK3jLKvgA3RlbyHpVOOA27M4Mwf_vVVJz7jjAy9eO6Epqr7qqnRVvmLsae26Sa11EiYpKXQDjQitroUJfTdBDDib2fnfvmtPz_Sbc3N-ZdQX9YQVeuCiuKM0iRq_tFRQirptZdQ9vpwoSwxI6BN9fTHmXTlMFVZv6XTjxlsytbJHS4xUdJtMamEoiRftTiTKhP1_yjJ_b5b8pWKaA9HJLXZzzCD5cZF8n12D4Ta7XmZKfr_D1uj96wt-PJ1JHobEPzbuA0eUAL9cfMWDPup1vrzg84HPaAIZooOP3KpLTj9l-fT959evROP4pk9reME7muFRuubKprGuwzGuAo2_u8vOTmafpqdinK0gOu3kSoCuk-z7HtCjwUJdJwgB3dFFi_l2MMZAUlqBIkZ600dLrC2hqwPYSQxOqXtsb1gM8IBxm4KxtosKMLkyYEMHMQaNxlFO1RIq9myjZ39ZKDR8Ln0r64tVPFrFZ6v4tmIvyRTbnUR_nR8gKPwICv8vUFTscGNIP_rk0lNFszXUgFqxJ9tl9CYqkYQBFuu8p_DfmIrdL3bfSqIwVcN0RlbM7iBiR9TdlWH-JTN2I-bx6GZtxZ5vwPNTrr_r4uH_0MUBuyEJ9bkH8ZDtrb6t4REmUqv4OPvMD2UNFyg priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELbGEBJfEO9kDGQkvoEh8UtiIyE0SqeBNECCon2z7OQClbZ064vE_j1nOykqFL7Grur4nus97p2fI-Rpbuoql7JhqhGcyQIK5kqZM-XaukIMGB3V-Y8_lkcT-eFEneyQod1Rv4GLrUe70E9qMj998fPi8g06_Ot0ZVy_XGAQChfFuGQq8HNWXiFXMTJVwVGPe7qftL65kYXp785s_-hGfIoy_tu4598llH_kUWN4OrxJbvS8kh4kINwiO9DdJtdSp8nLO2SFvwmrM3owGnPquoZ-KcxnitgBej47xeM_7vZ0cUanHR2HvmSIGdorri5o-KuWjj59e_-OFYYO1VvdK1qHzh6pli5N6rM9FKMthKZ4d8nkcPx1dMT6jgusloYvGci84W3bAvo5aMjzBpxDJzVeIwt3SilohBQggk69ar0OWi6uzh3oyjsjxD2y2806eECobpzSuvYCkHIp0K4G753k0Aojcg4ZeTbssz1Pwho2JsSFtskqFq1io1VsmZG3wRTrmUEUOz6Yzb_b3sdsU3mJQTnkHr0sS-5lizgM6jYK8HubjOwPhrQD0GzIc5YqlKVm5Ml6GH0sJE5cB7NVnJNUcVRG7ie7r1cikMAhyeEZ0RuI2Fjq5kg3_RF1vNET8ECndUaeD-D5va5_78Xe_1_jIbnOA55jzeE-2V3OV_AIidPSP47e8AsyHhLM priority: 102 providerName: Scholars Portal – databaseName: SpringerOpen Free (Free internet resource, activated by CARLI) dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9QwDLaWRUhcEG8KCwoSN4ho8-ik3JYyqwWJhwSL9hYlrQsjsZ3VzsyBf4-dtoMGlgPXJlWt-HPtxM5ngGd51cxyY1ppW62kKbCQoTS5tKFrZoSByiV2_vcfyuMT8-7Unu6Bmu7CpKL9RGmZftNTddjLFTkavgymjLQcg8vyClxl6nZGdV3W23MVzlyZohrvx-TaXfLqjg9KVP2XxZd_l0n-kStNLujoJtwYY0dxOEh7C_awvw3Xhm6SP-_Ahux-cyYO67kSoW_F56L6JAgfKM6XP2iLTyu6WJ2JRS_m3HuMcCFGVtWV4ONYUX_8-vaNLCoxVWj1r0TD3TuGerlh0pjREeRRkRvf3YWTo_mX-liOXRVkYyq1lmjyVnVdh2TL6DDPWwyBDLGKjiLtYK3FVhuNmrnobRcd87WEJg_oZjFUWt-D_X7Z4wMQrg3WuSZqpLDKogsNxhiMwk5XOleYwfNpnf35QJ7hU9JbOz9oxZNWfNKKLzN4zarYzmTi6_RgefHNj0Dw7SwacrycX4ymLFU0HWGNGWws0nfbDA4mRfrRGleec5ml5dLTDJ5uh8mOODkSelxu0pyB-cZmcH_Q-1YSTUEaBTIqA7eDiB1Rd0f6xffE1U1op02bcxm8mMDzW65_r8XD_5v-CK4rxneqMzyA_fXFBh9TsLSOT5J1_AInxQ1v priority: 102 providerName: Springer Nature |
Title | Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity |
URI | https://link.springer.com/article/10.1038/s41598-024-56260-6 https://www.ncbi.nlm.nih.gov/pubmed/38462662 https://www.proquest.com/docview/2954651074 https://www.proquest.com/docview/2955268405 https://pubmed.ncbi.nlm.nih.gov/PMC10925588 https://doaj.org/article/d7b43410739b4662b4f70496585e2efd |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExIvaHwubFRG4g2spbGdOLygLnQalTYmxlDfLCe5QCWWlKV94L_nzkk6la-XREosxfH9zne5u_yOsVdhWiShUqXQpYyEGsNYuFiFQruqSBADqfHs_Gfn8emVms31vA-4tX1Z5bAn-o26bAqKkR9RPirWVD74bvlDUNcoyq72LTTusl2iLqOSrmSebGIslMVS47T_VyaU5qhFe0X_lEVKaHLlRbxljzxt_998zT9LJn_Lm3pzdLLHHvR-JJ90gn_I7kD9iN3rOkv-fMzWuAesr_kkm0bc1SW_HKcXHLECfNl8x899XN1Fe80XNZ9SHzLECO8ZVltOoVmeffzy4b0Yp3yo1qrf8oI6eXS1c92gPrvD0boCNcF7wq5Opp-zU9F3WBCFSqOVABWWUVVVgHoNBsKwBOdQKdPcoNfttNZQSiVBEi-9rnJD3C2uCB2YJHeplE_ZTt3UsM-4KZ02psgloIulwbgC8typCCqZyjCCgL0e1tkuOyIN6xPg0thOKhalYr1UbBywYxLFZiSRYPsLzc1X2-uULZNcoRGmXGOu4jjKVYW4IzYbDfjcMmCHgyBtr5mtvcVRwF5ubqNOUaLE1dCs_ZiOBUcH7Fkn981MJDps6NREATNbiNia6vadevHN83Yj8vEDzpiAvRnAczuvf6_F8_-_xgG7HxGefY3hIdtZ3azhBTpKq3zktWHEdieT2eUMz8fT84tPeDWLs5EPPuDxTJlfLcsVbw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEB5VqRC8IG4MBRYJnsCqvYezRkKoTVMltA0VtFXflrW9hkjEDk0ilD_Fb2TGR6pwvfXVXsnrnW-O3Zn9BuBFEKfdQMrMV5ngvgxd6NtIBr6yedpFDMS6Yuc_GkWDU_n-XJ1vwM_2LgyVVbY2sTLUWZnSGfk25aMiReWD76bffeoaRdnVtoVGDYsDt_yBW7bZ2-Eeyvcl5_v9k97Ab7oK-KmM-dx3Msh4nucOsey0C4LMWYtAjBONkaZVSrlMSOEEcbGrPNHEV2LTwDrdTWxMB6Bo8jelwK1MBzZ3-6Pjj6tTHcqbyTBubucEQm_P0EPSLTYufUWbBz9a84BVo4C_Rbd_Fmn-lqmtHOD-LbjZRK5sp4babdhwxR24VveyXN6FBVqdxYTt9Pqc2SJjn8L4mCE6HZuW35aTEuU5nk3YuGB96nyGqGQNp-uM0WEw6304G-75Ycza-rDiDUupd0hdrVcPavJJDP25o7Z79-D0Slb_PnSKsnAPgenMKq3TRDgM6pTTNnVJYiV3uYhFwJ0Hr9p1NtOausNUKXehTS0Vg1IxlVRM5MEuiWI1kmi3qwflxRfTaLHJuolEt0_ZzURGEU9kjkgn_hzl8LuZB1utIE1jC2bmErkePF-9Ri2m1IwtXLmoxtS8O8qDB7XcVzMRGCJiGMU90GuIWJvq-pti_LViCkddwy2j1h68bsFzOa9_r8Wj___GM7g-ODk6NIfD0cFjuMEJ21WF4xZ05hcL9wTDtHnytNENBp-vWh1_Acz2Tgw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamIRAviDuBAUaCJ7Ca-JI4SAiNXrQyGJNgqG-ekzhQiSZlbYX61_h1nOMkncrtba-JpTg-37nY5_g7hDwN0zwJpSyYKgRnMnIRs7EMmbJlngAGUu3Z-d8fxQcn8u1ETXbIz-4uDJZVdjbRG-qizvGMvIf5qFhh-WCvbMsijgej1_PvDDtIYaa1a6fRQOTQrX_A9m3xajwAWT_jfDT81D9gbYcBlsuUL5mTYcHLsnSAa6ddGBbOWgBlmmmIOq1SyhVCCieQl12VmUbuEpuH1ukksykehoL5v5QIFaGOJZNkc76DGTQZpe09nVDo3gJ8Jd5n45Ip3EaweMsX-pYBf4tz_yzX_C1n613h6Dq51sawdL8B3Q2y46qb5HLT1XJ9i6zA_qxmdL8_5NRWBf0YpccUcOrovP62ntUg2eliRqcVHWIPNMAnbdldFxSPhWn_w-fxgEUp7SrFqpc0xy4iTd1eM6jNLFHw7A4b8N0mJxey9nfIblVX7h6hurBK6zwTDsI75bTNXZZZyV0pUhFyF5Dn3TqbeUPiYXzyXWjTSMWAVIyXiokD8gZFsRmJBNz-QX32xbT6bIokkxAAYJ4zk3HMM1kC5pFJRzn4bhGQvU6QprUKC3OO4YA82bwGfcYkja1cvfJjGgYeFZC7jdw3MxEQLEJAxQOitxCxNdXtN9X0q-cMB62DzaPWAXnRged8Xv9ei_v__43H5AoooXk3Pjp8QK5yhLYvddwju8uzlXsI8doye-QVg5LTi9bEX7CWUNw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+ACE2+and+S19P+gene+polymorphism+in+Egyptian+patients+with+COVID-19+infection%3A+correlation+with+disease+severity&rft.jtitle=Scientific+reports&rft.au=Gaber%2C+Dalia+A&rft.au=Shokr%2C+Mohamed&rft.au=Shaker%2C+Olfat&rft.au=Zaki%2C+Kamelia+Ahmed&rft.date=2024-03-10&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=14&rft.issue=1&rft.spage=5846&rft_id=info:doi/10.1038%2Fs41598-024-56260-6&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |